Published October 6, 2015 | Version v1
Patent Open

Role of ADAM10 and its relevance to disease and therapeutics

  • 1. University of Chicago

Contributors

Description

Certain embodiments are directed to compositions and methods of inhibiting pathogenic bacterial infection involving ADAMIO comprising administering an effective amount of a metalloprotease inhibitor to a patient. Certain embodiments are directed to method of inhibiting Staphylococcal infection comprising administering an effective amount of a metalloprotease inhibitor to a patient. Other embodiments concern methods of inhibiting infection by a bacteria from the genus Clostridium, Streptococcus, Listeria, Bacillus, or Arcanobacterium.

Files

US9150865.pdf

Files (2.5 MB)

Name Size Download all
md5:6860aad339ff8d64e8fbbad274bf5e65
2.5 MB Preview Download

Additional details

Identifiers

Patent number
US 201113884502 A
Patent application number
US 9150865 B2
Other
oai:uchicago.tind.io:8291

Dates

Patent filed
2011-11-09

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Microbiology, Pediatrics, Medicine